Focus Article
Preservation is the Buzzword for 2026
As the cannabis industry readies for the growth surge rescheduling could trigger, it’s getting dangerously close to losing its grip on the craft sector. We are entering the era of the connoisseur, where consumer palates are becoming increasingly sophisticated and demand products that provide a full-spectrum craft experience. They understand the nuances of cannabis and […]
The Case For Cannabis Telemedicine: Can it Work in the US?
It has been one year since Germany fully legalized cannabis on April 1, 2024, following the launch of its medical program in 2017. While cannabis was removed from the narcotics list, Germany continues to take a medical-first approach. Few expect full adult-use legalization anytime soon, particularly after a conservative government was elected last year. According […]
Are Triploids The Next Big Thing In Cultivation?
It all starts with genetics. The possibilities for manipulating the cannabis plant through breeding and cultivation are expanding rapidly, and advancements in methods for achieving optimal plant expression are accelerating as the industry moves into 2026. Breeders and cultivators are increasingly banding together to share knowledge and resources, while high-tech equipment and analytical tools are […]
New York’s Cannabis Boom Is Real, But So Are the Risks
The Most Exciting US Market No cannabis market in the United States has experienced a more compelling growth trajectory over the past two years than New York. After a halting and often-criticized launch, the state’s legal adult-use market has accelerated at an unmatched pace. In 2023, New York generated a paltry $100 million in legal […]
How Cannabis Brands Plan To Drive Retail Sales in 2026
Retailers are not in the business of building brands. They are in the business of selling products. The most effective way to earn buyer attention is still the same: proven sales velocity paired with brand awareness that brings customers through the door. Retail Is the Battleground Brendan McKee, co-founder of Massachusetts dispensary Silver Therapeutics, wants […]
New Study Shows Chromatin Accessibility as Key Factor in Cannabis Potency and Flavor
Genetics determines cannabis potency, flavor, and therapeutic value. Choose the right cultivar, stabilize the right traits, and the chemistry will follow. But a new in-depth biological study suggests that genetics may be only part of the equation. A recent study published in Frontiers in Plant Science reveals that chromatin accessibility—an epigenetic mechanism that determines whether […]
Platform Launches Insurance Coverage for Medical Cannabis
A Cleveland-based health-tech company, EM2P2, has launched a platform that could change how Americans pay for medical cannabis. Its new product, CannaLnx, claims to make cannabis care reimbursable, compliant, and accessible by finally allowing patients to apply health-benefit dollars toward cannabis purchases in legal states. Developed as the exclusive tech partner of the American Council […]
The Fight Against New York’s METRC Monopoly Heats Up
There is a growing fear among New York cannabis operators that the lawsuit challenging Metrc’s Retail ID program will “kill track and trace” and return the state to the chaos of inversion and inventory failures experienced last year. That fear is understandable. It is also wrong. Retail ID is not track-and-trace. Retail ID is a […]
Why Most Cannabis COGS Would Fail an Audit — and How Operators Can Fix It
For cannabis operators, the cost of goods sold (COGS) is far more than an accounting line item. It’s the most critical financial number in the entire business. Under IRC Section 280E, most ordinary business deductions are disallowed, making COGS the primary mechanism for reducing taxable income. At the same time, COGS drives pricing decisions, product […]